日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Generation of antagonistic biparatopic anti-CD30 antibody from an agonistic antibody by precise epitope determination and utilization of structural characteristics of CD30 molecule.

通过精确确定表位并利用 CD30 分子的结构特征,从激动性抗体生成拮抗性双位点抗 CD30 抗体

Akiba Hiroki, Ise Tomoko, Satoh Reiko, Abe Yasuhiro, Tsumoto Kouhei, Ohno Hiroaki, Kamada Haruhiko, Nagata Satoshi

CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis

CD21(-/low)边缘区B细胞高表达Fc受体样5蛋白,并在丙型肝炎病毒相关混合型冷球蛋白血症血管炎中被抗Fc受体样5免疫毒素杀死。

Terrier, Benjamin; Nagata, Satoshi; Ise, Tomoko; Rosenzwajg, Michelle; Pastan, Ira; Klatzmann, David; Saadoun, David; Cacoub, Patrice

FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins

FCRL1 在慢性淋巴细胞白血病、毛细胞白血病和 B 细胞非霍奇金淋巴瘤中作为免疫毒素的靶点

Du, Xing; Nagata, Satoshi; Ise, Tomoko; Stetler-Stevenson, Maryalice; Pastan, Ira

Evolution and expression of chimeric POTE-actin genes in the human genome

人类基因组中嵌合POTE-肌动蛋白基因的进化和表达

Lee, Yoomi; Ise, Tomoko; Ha, Duc; Saint Fleur, Ashley; Hahn, Yoonsoo; Liu, Xiu-Fen; Nagata, Satoshi; Lee, Byungkook; Bera, Tapan K; Pastan, Ira

Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy

CD30上的细胞膜特异性表位:潜在的免疫治疗更优靶点

Nagata, Satoshi; Ise, Tomoko; Onda, Masanori; Nakamura, Kazuyasu; Ho, Mitchell; Raubitschek, Andrew; Pastan, Ira H

Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression

肿瘤抑制因子p53/p73与CCAAT结合转录因子2 (CTF2)的物理相互作用以及对人高迁移率族蛋白1 (HMG1)基因表达的差异性调控

Uramoto, Hidetaka; Izumi, Hiroto; Nagatani, Gunji; Ohmori, Haruki; Nagasue, Naofumi; Ise, Tomoko; Yoshida, Takeshi; Yasumoto, Kosei; Kohno, Kimitoshi